The role of double-lumen irrigation-suction tube in the treatment of disseminated Fournier's gangrene: a single-center retrospective cohort study

双腔灌注吸引管在治疗播散性坏疽性筋膜炎中的作用:一项单中心回顾性队列研究

阅读:1

Abstract

BACKGROUND: The double-lumen irrigation-suction tube (DLIST) has demonstrated excellent efficacy in the treatment of complex infectious diseases; however, its application value in disseminated Fournier's gangrene (FG) remains undetermined. This research aims to assess the clinical efficacy and feasibility of DLIST in the treatment of disseminated FG. METHODS: A retrospective analysis was conducted on the clinical data of 34 patients with disseminated FG admitted from October 2012 to February 2025. The severity of the disease was evaluated using the Fournier's Gangrene Severity Index (FGSI) and the modified Uludag Fournier's Gangrene Severity Index (UFGSI). The patients were divided into the DLIST group (group A) and the conventional dressing change group (group B) according to whether the DLIST technique was used after debridement. Data from the two groups were compared and analyzed. RESULTS: Sixteen patients were treated with DLIST irrigation and suction, and 18 patients were treated with conventional dressing changes. No statistically significant differences were observed in FGSI and UFGSI scores between the two groups (P=0.49 and P=0.28, respectively). Compared with the conventional group, the DLIST group had significantly shorter wound closure time, lower daily gauze change frequency, reduced analgesic use frequency, and lower visual analogue scale scores (P=0.02, P<0.001, P<0.001, and P=0.02, respectively). The length of hospital stay (LOS) was also significantly shorter in the DLIST group (P=0.02). No deaths occurred in either group during the observation period. CONCLUSIONS: The application of DLIST after debridement significantly shortens wound closure time and LOS in patients with disseminated FG, while reducing dressing change frequency and alleviating pain. However, these results require further validation through large-scale, prospective, randomized controlled trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。